Sun Yat-sen University Cancer Center (SYSUCC)
Hodgkin's lymphoma treatment cost in China typically includes specialized diagnostics like PET-CT scans and primary treatments such as chemotherapy, which ranges from $14,800 to $31,000. Radiation therapy runs from $7,500 to $14,500. Total expenses depend on the disease stage and drug regimens used. Patients can save approximately 50-70% compared to US costs. Top treatment centers are located in Beijing, Guangzhou, and Chengdu.
Typical Hodgkin's Lymphoma Treatment Costs in China
Bookimed Expert Insight: Patients seeking high-volume clinical expertise should consider Sun Yat-sen University Cancer Center (SYSUCC). This JCI-accredited facility managed over 1.84 million outpatient visits in 2023. It offers advanced nuclear medicine and radionuclide production for precise lymphoma staging. For complex hematology cases, Beijing-based specialists at Lu Daopei Hematology Hospital provide deep expertise in hematologic oncology. Advanced interventional oncology is accessible at Uni-asia Cancer Hospital in Chengdu.
| China | Turkey | Austria | |
| Radiation therapy for colorectal cancer | ≈ $7,500 | from $5,000 | from $6,700 |
| Chemotherapy for breast cancer | ≈ $14,800 | from $3,000 | ≈ $9,500 |
| Chemotherapy | from $18,800 | from $1,800 | from $990 |
| Biological therapy | ≈ $6,000 | ≈ $2,500 | ≈ $7,500 |
| Immunotherapy with Keytruda (Pembolizumab) | ≈ $4,500 | from $3,900 | ≈ $5,800 |
No hidden fees – just official clinic prices. Pay at the clinic for Hodgkin's lymphoma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Hodgkin's lymphoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Hodgkin's lymphoma treatment journey.
Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).
He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.
Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.